Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China

Objective This study aimed to evaluate endothelial microparticles (EMPs) as a potential prognostic marker in hemolytic disease of the Chinese neonate. Methods We compared 29 newborns with ABO hemolytic disease of the newborn (ABO HDN), 22 newborns with Rh HDN, and 21 healthy newborns with matched mo...

Full description

Bibliographic Details
Main Authors: Xiao-jing Zhu, Jin-kai Wei, Cong-min Zhang
Format: Article
Language:English
Published: SAGE Publishing 2019-11-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/0300060519870947
_version_ 1819140996006412288
author Xiao-jing Zhu
Jin-kai Wei
Cong-min Zhang
author_facet Xiao-jing Zhu
Jin-kai Wei
Cong-min Zhang
author_sort Xiao-jing Zhu
collection DOAJ
description Objective This study aimed to evaluate endothelial microparticles (EMPs) as a potential prognostic marker in hemolytic disease of the Chinese neonate. Methods We compared 29 newborns with ABO hemolytic disease of the newborn (ABO HDN), 22 newborns with Rh HDN, and 21 healthy newborns with matched mother and infant blood groups (controls). Markers of hemolysis and von Willebrand factor antigen (vWF Ag) were analyzed. EMP (CD144+) levels were measured before and after therapy. Results vWF Ag and pretherapy EMP levels were higher in the ABO HDN and Rh HDN groups than in the control group. Additionally, vWF Ag and pretherapy EMP levels were significantly higher in the ABO HDN group than in the Rh HDN group. Posttherapy EMP levels were decreased compared with pretherapy levels in the ABO HDN and Rh HDN groups. Moreover, hemoglobin and indirect bilirubin levels were independently correlated with pretherapy EMP levels in the ABO HDN group. Conclusion Our findings indicate that EMP measurement in neonates with HDN may provide a novel method of monitoring possible severe vascular dysfunction in patients in China. An external validation in larger datasets is necessary for further study.
first_indexed 2024-12-22T11:47:25Z
format Article
id doaj.art-71818c4f43ec457ca9c508eb1ce64cf4
institution Directory Open Access Journal
issn 0300-0605
1473-2300
language English
last_indexed 2024-12-22T11:47:25Z
publishDate 2019-11-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-71818c4f43ec457ca9c508eb1ce64cf42022-12-21T18:27:07ZengSAGE PublishingJournal of International Medical Research0300-06051473-23002019-11-014710.1177/0300060519870947Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in ChinaXiao-jing ZhuJin-kai WeiCong-min ZhangObjective This study aimed to evaluate endothelial microparticles (EMPs) as a potential prognostic marker in hemolytic disease of the Chinese neonate. Methods We compared 29 newborns with ABO hemolytic disease of the newborn (ABO HDN), 22 newborns with Rh HDN, and 21 healthy newborns with matched mother and infant blood groups (controls). Markers of hemolysis and von Willebrand factor antigen (vWF Ag) were analyzed. EMP (CD144+) levels were measured before and after therapy. Results vWF Ag and pretherapy EMP levels were higher in the ABO HDN and Rh HDN groups than in the control group. Additionally, vWF Ag and pretherapy EMP levels were significantly higher in the ABO HDN group than in the Rh HDN group. Posttherapy EMP levels were decreased compared with pretherapy levels in the ABO HDN and Rh HDN groups. Moreover, hemoglobin and indirect bilirubin levels were independently correlated with pretherapy EMP levels in the ABO HDN group. Conclusion Our findings indicate that EMP measurement in neonates with HDN may provide a novel method of monitoring possible severe vascular dysfunction in patients in China. An external validation in larger datasets is necessary for further study.https://doi.org/10.1177/0300060519870947
spellingShingle Xiao-jing Zhu
Jin-kai Wei
Cong-min Zhang
Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
Journal of International Medical Research
title Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
title_full Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
title_fullStr Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
title_full_unstemmed Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
title_short Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China
title_sort evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in china
url https://doi.org/10.1177/0300060519870947
work_keys_str_mv AT xiaojingzhu evaluationofendothelialmicroparticlesasaprognosticmarkerinhemolyticdiseaseofthenewborninchina
AT jinkaiwei evaluationofendothelialmicroparticlesasaprognosticmarkerinhemolyticdiseaseofthenewborninchina
AT congminzhang evaluationofendothelialmicroparticlesasaprognosticmarkerinhemolyticdiseaseofthenewborninchina